J 233 (Oxcarbazepine 300 mg)
Pill with imprint J 233 is Orange, Elliptical/Oval and has been identified as Oxcarbazepine 300 mg. It is supplied by Cadista Pharmaceuticals Inc. .
Oxcarbazepine is used in the treatment of seizures; epilepsy and belongs to the drug class dibenzazepine anticonvulsants. Risk cannot be ruled out during pregnancy. Oxcarbazepine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for J 233
Oxcarbazepine
- Imprint
- J 233
- Strength
- 300 mg
- Color
- Orange
- Size
- 15.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Dibenzazepine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cadista Pharmaceuticals Inc.
- National Drug Code (NDC)
- 59746-0233 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
hypromelloses,
ferric oxide yellow,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
magnesium silicate,
titanium dioxide,
ferric oxide red
Note: Inactive ingredients may vary.
More about oxcarbazepine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (316)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: dibenzazepine anticonvulsants
Patient resources
- Drug Information
- Oxcarbazepine (Advanced Reading)
- Oxcarbazepine Extended-Release Tablets
- Oxcarbazepine Tablets
- Oxcarbazepine Oral Suspension
- Other brands
- Trileptal, Oxtellar XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.